iShares Biotechnology ETF Rating $145.58 -2.40 (-1.62%) (As of 09/23/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends iShares Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy2.63Holdings in IBB have an aggregate rating of Moderate Buy based on 740 analyst ratings issued in the past year covering 50 companies (85.0% of the portfolio).IBB Aggregate Price Target$166.1814.15% UpsideHigh Prediction$213.21Average Prediction$166.18Low Prediction$117.23Holdings in IBB have an aggregate price target of $166.18 and a range of $117.23 to $213.21 covering 50 companies (85.0% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.56%GILDGilead Sciences$83.99+0.1%4.6008 of 5 stars4.60 / 5 stars2.45$82.06 -2.3%208.78%REGNRegeneron Pharmaceuticals$1,091.98-4.6%4.2325 of 5 stars4.23 / 5 stars2.85$1,111.30 1.8%20Analyst ForecastHigh Trading Volume7.97%AMGNAmgen$335.61-0.5%4.6836 of 5 stars4.68 / 5 stars2.55$327.28 -2.5%227.76%VRTXVertex Pharmaceuticals$460.00-1.1%4.3043 of 5 stars4.30 / 5 stars2.50$486.36 5.7%26Positive News4.02%IQVIQVIA$240.75-0.6%4.934 of 5 stars4.93 / 5 stars2.82$267.00 10.9%17Analyst Forecast3.14%ALNYAlnylam Pharmaceuticals$271.83-0.7%4.1524 of 5 stars4.15 / 5 stars2.71$279.14 2.7%242.75%MTDMettler-Toledo International$1,405.900.0%4.1931 of 5 stars4.19 / 5 stars1.88$1,356.25 -3.5%8Positive News2.72%BIIBBiogen$195.81-1.8%4.8646 of 5 stars4.86 / 5 stars2.68$275.30 40.6%25Analyst Forecast2.58%ARGXargenx$528.50-0.8%2.1117 of 5 stars2.11 / 5 stars2.91$547.74 3.6%222.24%MRNAModerna$64.14-2.4%4.5072 of 5 stars4.51 / 5 stars2.11$100.44 56.6%19Gap Up2.03%BNTXBioNTech$113.05+0.7%3.229 of 5 stars3.23 / 5 stars2.64$124.54 10.2%14Gap Up1.91%ILMNIllumina$130.10-0.8%4.565 of 5 stars4.57 / 5 stars2.57$151.05 16.1%231.82%WATWaters$339.71+0.9%3.7602 of 5 stars3.76 / 5 stars2.20$318.50 -6.2%151.52%BGNEBeiGene$201.31-0.3%1.4078 of 5 stars1.41 / 5 stars2.71$241.21 19.8%7Gap Up1.50%BMRNBioMarin Pharmaceutical$69.13-2.2%4.9867 of 5 stars4.99 / 5 stars2.68$98.84 43.0%221.43%GMABGenmab A/S$24.14-5.4%4.7271 of 5 stars4.73 / 5 stars2.46$45.20 87.2%13Analyst ForecastGap DownHigh Trading Volume1.37%NTRANatera$123.54-3.3%1.7441 of 5 stars1.74 / 5 stars3.00$120.07 -2.8%15Insider Selling1.34%UTHRUnited Therapeutics$355.59+0.7%4.664 of 5 stars4.66 / 5 stars2.64$357.17 0.4%14Analyst ForecastPositive News1.18%INSMInsmed$71.82-3.2%4.2254 of 5 stars4.23 / 5 stars3.00$81.40 13.3%161.15%INCYIncyte$64.12-2.5%4.8624 of 5 stars4.86 / 5 stars2.32$73.24 14.2%191.14%NBIXNeurocrine Biosciences$117.75-0.5%4.9895 of 5 stars4.99 / 5 stars2.83$162.20 37.7%241.12%PCVXVaxcyte$112.11-2.7%3.4657 of 5 stars3.47 / 5 stars3.00$147.50 31.6%7Positive NewsGap Up1.09%TECHBio-Techne$77.21-1.4%4.3202 of 5 stars4.32 / 5 stars2.70$80.60 4.4%10Analyst Revision1.06%SRPTSarepta Therapeutics$124.79-1.9%4.8772 of 5 stars4.88 / 5 stars2.95$187.39 50.2%19Analyst ForecastAnalyst Revision0.94%CRLCharles River Laboratories International$203.83-1.0%4.8596 of 5 stars4.86 / 5 stars2.23$227.55 11.6%13Analyst Forecast0.84%MEDPMedpace$361.95-1.0%4.9663 of 5 stars4.97 / 5 stars2.78$420.88 16.3%9Analyst Forecast0.75%LEGNLegend Biotech$45.92-5.4%3.2833 of 5 stars3.28 / 5 stars3.00$81.78 78.1%13Analyst RevisionPositive News0.73%HALOHalozyme Therapeutics$58.53-1.2%4.732 of 5 stars4.73 / 5 stars2.67$60.00 2.5%90.71%ITCIIntra-Cellular Therapies$75.81-2.3%4.8799 of 5 stars4.88 / 5 stars2.83$96.58 27.4%120.71%EXELExelixis$26.36-0.2%4.4213 of 5 stars4.42 / 5 stars2.67$27.67 5.0%15Analyst Forecast0.70%RGENRepligen$140.43-1.8%4.913 of 5 stars4.91 / 5 stars2.80$188.38 34.1%100.60%BRKRBruker$67.16-0.6%4.7937 of 5 stars4.79 / 5 stars2.60$81.40 21.2%10Analyst Revision0.59%ROIVRoivant Sciences$11.90-0.6%3.6535 of 5 stars3.65 / 5 stars2.90$17.39 46.1%10High Trading Volume0.55%RVMDRevolution Medicines$42.63-6.1%4.0704 of 5 stars4.07 / 5 stars3.09$53.45 25.4%110.55%CYTKCytokinetics$52.09-3.1%4.4274 of 5 stars4.43 / 5 stars2.73$80.67 54.9%15Analyst Forecast0.53%ASNDAscendis Pharma A/S$146.60-3.1%3.4016 of 5 stars3.40 / 5 stars2.93$193.77 32.2%14Analyst Forecast0.52%IONSIonis Pharmaceuticals$41.83-2.2%4.2857 of 5 stars4.29 / 5 stars2.71$60.68 45.1%21Positive News0.49%BPMCBlueprint Medicines$90.06-1.8%3.2137 of 5 stars3.21 / 5 stars2.74$120.00 33.2%19Positive News0.47%RAREUltragenyx Pharmaceutical$57.56-2.0%4.7425 of 5 stars4.74 / 5 stars2.93$87.43 51.9%140.45%KRYSKrystal Biotech$180.18-2.2%4.6526 of 5 stars4.65 / 5 stars3.00$196.75 9.2%9Positive News0.42%RNAAvidity Biosciences$43.50-2.2%3.1567 of 5 stars3.16 / 5 stars3.00$61.00 40.2%7Insider Selling0.42%ALKSAlkermes$28.10-1.6%4.6005 of 5 stars4.60 / 5 stars2.55$36.70 30.6%110.39%MDGLMadrigal Pharmaceuticals$225.72-3.3%4.2269 of 5 stars4.23 / 5 stars2.69$343.83 52.3%13Analyst Upgrade0.38%ADMAADMA Biologics$20.03+0.3%2.3867 of 5 stars2.39 / 5 stars3.25$15.50 -22.6%4Analyst ForecastHigh Trading Volume0.36%BBIOBridgeBio Pharma$25.40-5.0%4.7214 of 5 stars4.72 / 5 stars2.92$47.92 88.6%120.36%CRNXCrinetics Pharmaceuticals$50.42-5.1%4.4327 of 5 stars4.43 / 5 stars2.91$68.55 35.9%110.35%CRSPCRISPR Therapeutics$46.74-3.0%2.6119 of 5 stars2.61 / 5 stars2.37$75.63 61.8%190.35%APLSApellis Pharmaceuticals$32.72+0.6%4.3517 of 5 stars4.35 / 5 stars2.80$70.53 115.6%15Analyst Forecast0.34%AXSMAxsome Therapeutics$91.56-4.5%4.8119 of 5 stars4.81 / 5 stars3.00$124.57 36.1%140.31%DNLIDenali Therapeutics$30.24-2.2%4.3511 of 5 stars4.35 / 5 stars2.89$38.33 26.8%9 This page (NASDAQ:IBB) was last updated on 9/23/2024 by MarketBeat.com Staff From Our PartnersElection Shocker: Trump Won't See This ComingIf you suspect Democrats will play dirty games in this election… You are RIGHT! Executive Order 14019 ha...Banyan Hill Publishing | SponsoredInvesting Legend Warns: “Disturbing Event Is Coming to America”America Repeats Act That's Destroyed Stock Markets For 200 Years The Fed has now repeated a mistake that ce...Stansberry Research | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding iShares Biotechnology ETF You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts